3 months ago

Dr Mike Yeadon Full Interview (2025)

🧑‍🔬 Education and Early Career

- PhD in Pharmacology
- Earned from the University of Surrey (UK) in the early 1980s.
- Specialized in respiratory pharmacology, focusing on mechanisms of asthma and allergy.

💼 Pfizer Inc. (1995–2011)

Role: Vice President and Chief Scientist, Allergy & Respiratory Research
Division: Pfizer Global R&D in Sandwich, Kent, UK
Duration: Approximately 16 years

Key Achievements:
- Led teams working on treatments for asthma, chronic obstructive pulmonary disease (COPD), and allergic conditions.

- Oversaw drug discovery programs; contributed to the development of several compounds, some reaching late-stage clinical trials.

- Recognized within the industry as a senior scientist with expertise in inhaled and oral therapies for respiratory disease.

🧪 Ziarco Pharma Ltd. (2012–2016)
Co-founder and CEO

Founded Ziarco, a biotech firm focused on developing new treatments for inflammatory and allergic diseases, using assets licensed from Pfizer.

Milestone:

In 2016, Ziarco was acquired by Novartis for a reported sum in the hundreds of millions of dollars (exact amount undisclosed).

The acquisition was driven by the promise of Ziarco’s lead compound for eczema and other allergic skin diseases.

🎙️ COVID-19 Pandemic (2020–Present)
Transitioned to Public Commentary and Activism

In early 2020, Yeadon began publicly challenging UK and global COVID-19 policies.

Main Themes of His Advocacy:
- Questioned the accuracy of PCR testing.
- Claimed the pandemic’s severity was overstated.
- Argued that natural immunity was under-recognized.
- Suggested that COVID-19 vaccines were dangerous, and even raised fertility concerns.